Submitted by Anonymous (not verified) on 20 August 2025 - 10:25
Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Status: Authorised